Past research indicates that physical health measures (such as all-cause mortality) improve when economic conditions temporarily deteriorate, but the relationship is unclear for behavioral health. The pro-cyclicality of mortality has declined in recent years at the same time that drug poisoning deaths have trended sharply upwards, suggesting a connection to the rising use of many types of drugs. We contribute new evidence to the literature by examining how severe, adverse outcomes related to use of opioid analgesics (hereafter abbreviated as opioids) and other drugs vary with shortterm fluctuations in macroeconomic conditions. We use data on deaths and emergency department (ED) visits related to opioid and other drug poisonings together with information on state and county unemployment rates. We focus on opioids because they are a major driver of the recent, fatal drug epidemic. We use county level mortality data for the entire U.S. from 1999-2014, and state and county level ED data covering 2002-2014 from a subset of states. We find that as the county unemployment rate increases by 1 percentage point, the opioid death rate (per 100k) rises by 0.12 (2.2%) and the ED visit rate for opioid overdoses (per 100k) increases by 0.82 (6.1%). We also uncover statistically significant increases in the overall drug death rate that are mostly driven by increases in opioid deaths. These results also hold at the state level. In most specifications, both the county and state results are primarily driven by adverse events among whites. Additionally, we find that the relationship is relatively stable across time periods; thus, these results do not only pertain to recession years, but instead represent a more generalizable connection between economic development and the severe adverse consequences of substance abuse that has thus far been unexplored.
"black") drug fatality rates closely tracked each other during the 1980s and 1990s, but since 1999 (the period examined here), white mortality rates have grown much faster. Figure 2 illustrates this divergence. From 1999 to 2014 the U.S. white drug death rate per 100,000 grew by 203%, while the black and Hispanic drug death rate increased by 49% and 31%, respectively. However, rising deaths are not the only indication of serious health consequences related to the growing use of opioids.
Emergency department (ED) visits involving narcotic pain relievers increased 117% between 2005
and 2011 (Crane 2015) and opioid related ED poisonings have increased by 46% from 2006 to 2014 (see Figure 3 ). While this increase has mostly been driven by prime aged adults, all age groups have seen an increase in the risk of opioid poisonings ED visits (Tadros et al., 2016) .
This analysis examines how serious adverse health outcomes related to opioid and other drug abuse vary with short-term fluctuations in macroeconomic conditions. Specifically, we examine how deaths and emergency department visits due to opioids and all drug overdoses are related to local unemployment rates. Our main findings are that both deaths and ED visits related to opioid overdoses rise when county unemployment rates temporarily increase. The same is true when examining all sources of drug poisoning mortality and consistent results are obtained when: performing the analysis at the state-level rather than the county-level; proxying for macroeconomic conditions with employment-to-population ratios rather than unemployment rates; and when conducting a variety of other robustness checks. Importantly, our findings are relatively stable regardless of the time period considered, indicating that our results represent a general connection between economic conditions and severe adverse consequences of substance abuse and are not restricted to periods of recession.
Moreover, our mortality results are predominately driven by changes among whites (rather than blacks or Hispanics).
II. Prior Research and Contribution of this Investigation
The literature examining the connection between economic fluctuations and health is vast, and has considered effects on mortality, morbidity, as well as health related behaviors, health insurance and health care use. 4 Mortality has historically been found to be procyclical in studies covering a wide variety of countries and time periods (e.g. Ruhm, 2000; Neumayer, 2004; Tapia Granados, 2005; Gerdtham & Ruhm, 2006; Buchmueller, et al., 2007; Lin, 2009; Gonzalez & Quast, 2011; and Ariizumi & Schirle, 2012) . Similarly, many (although not all) studies suggest that lifestyle factors such as exercise, obesity, smoking and heavy drinking become healthier in bad economic times (e.g. see Freeman, 1999; Ruhm & Black, 2002; Ruhm, 2005; Gruber & Frakes, 2006; and Xu, 2013) . 5 However, some current research suggests that these patterns may have been weakened or reversed in recent years for both mortality (McInerney & Mellor, 2012; Stevens et al., 2015; Lam & Piérard, 2015; and Ruhm, 2015) and health behaviors (Dávlos et al., 2012; Colman & Dave, 2013; and Tekin et al., 2013) .
Particularly relevant to the current analysis is suggestive evidence, provided by Ruhm (2015) , that one of the main reasons deaths have moved from being sharply procyclical to acyclical or countercyclical in recent years is because poisoning fatalities have been rapidly increasing and now exhibit a strong countercyclical pattern. However, the precision of those estimates is low and that analysis does not separately examine drug poisoning fatalities or poisonings involving any specific drugs such as opioids. 6 Although there has been substantial investigation of the relationship between macroeconomic conditions and a variety of health behaviors -including drinking, smoking and exercise, as discussed above -corresponding effects on drug use have received less attention (largely because of data limitations). Arkes (2007) provides evidence that the teenage use of both marijuana and harder (illicit) drugs rises in bad economic times. Using data from 2002-2013 and a broader age range, Carpenter et al. (2016) find that economic downturns are associated with increases in self-reported substance use of hallucinogens (particularly ecstasy) but with insignificant effects for most other drugs. However, when examining self-reported substance use disorders, they find results for analgesics (which include opioids and non-opioid forms) as well as for hallucinogens. Whether these estimated effects are large enough to result in higher rates of ED visits or deaths is unclear. Frijters et al. (2013) show that internet searches for terms related to alcohol abuse and treatment increase during bad economic times. However, Maclean, Cantor, and Pacula's (2015) analysis of data from 1992-2010 suggests that alcohol and illicit drug admissions to (non-emergency department)
substance abuse programs decrease in such periods. The exact mechanisms driving this decrease are unclear, as the use of substance abuse programs depends on both underlying health status and changes in the availability of treatment in ways that are hard to disentangle. 7 If temporary economic downturns simultaneously increase the demand for but lower access to treatment, the net result might be an rise in both deaths and ED visits.
Our analysis extends beyond prior research by focusing on drug poisonings, which have grown rapidly in the past fifteen years and are likely to be related to economic conditions in different ways than other types of poisoning. Furthermore, we focus on the severe outcomes of ED visits and deaths. While examining all types of drug overdoses, we pay particular attention to those involving opioids. We base this decision on the fact that opioids comprise the majority of drug overdose deaths and are quite probably the most sensitive to macroeconomic conditions. For example, opioids were estimated to be involved in 53% of fatal drug overdoses in 2014 and in 64% of the increase in drug deaths occurring between 1999 and 2014 (Ruhm 2017) . Next most important was heroin -estimated to be involved in 30% of 2014 drug fatalities. However, while do not focus on heroin here because rates of heroin death and ED visits were relatively low for most of our study period (until 2010) after which they rose very rapidly.
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We separately examine the connection between economic conditions and drug poisonings and deaths for whites, blacks, and Hispanics. Differences across racial groups may be important given recent evidence by Case and Deaton (2015) that mortality rates increased for 45-54 year old non-Hispanic whites, even while they rapidly decreased for blacks and Hispanics. Although poisonings are an important source of the observed changes in mortality rates, it is not obvious that the effects of macroeconomic conditions on deaths or emergency department visits involving opioids will follow the same pattern. For instance, to the extent that minorities are more affected by economic downturns, we might anticipate stronger patterns for non-whites than whites. On the other hand, drug deaths have grown more slowly for nonwhites than whites since 1999 (Ruhm 2017 ) which might predict a weaker relationship.
III. Data and Descriptive Statistics
Mortality data come from the National Vital Statistics System of the Centers for Disease
Control and Prevention Multiple Cause of Death (MCOD) files for 1999-2014, which provide information from death certificates (Centers for Disease Control and Prevention, 2016) . Mortality data are one of the few sources of health information collected for a long period of time and in a relatively comparable manner across areas of the country. The MCOD provide information on: a single underlying cause of death (UCD), up to twenty additional causes and basic demographics.
Cause-of-death was categorized using four-digit International Classification of Diseases, Tenth
Revision (ICD-10) codes with details also provided on place of residence, age, race/ethnicity, gender, 8 These statistics refer to any involvement of these drugs rather than the exclusive involvement of a particular drug. The distinction is important because many drug poisoning deaths involve combinations of drug classes (e.g. 49% in 2014 according to Ruhm 2017) .
year, and weekday of death. We obtained a restricted use version of the data with information on the state and county of residence for use in this study.
Drug poisoning deaths were defined using ICD-10 UCD codes, where the underlying cause is the "disease or injury that initiated the chain of morbid events that led directly and inevitably to death" (Centers for Disease Control and Prevention, 2014 in 20%-25% of fatal overdoses (Ruhm 2017) . To correct for this undercount, we impute opioid or heroin involvement in cases where the death certificate indicated only unspecified drugs. To do so,
we estimated probit models on the sample of fatal overdoses where at least one drug was specified.
The dichotomous dependent variable was set to one if opioids were mentioned and to zero if they were not. The explanatory variables included dichotomous indicators for: sex, race (white, black, other nonwhite), Hispanic origin, currently married, education (high school dropout, high school graduate, some college, college graduate), age categories (≤20, 21-30, 31-40, 41-50, 51-60, 61-70, 71-80, >80) , day of the week of death (seven dummy variables) and a vector of state fixed-effects.
The probit models were estimated separately for each year. Next, we use the probit results to calculate year-specific predicted probabilities of opioid-involvement for cases where no drug was specified on the death certificate. Adjusted mortality rates were then calculated using reported involvement for deaths where at least one specific drug was mentioned and using the imputed probabilities where no drug was specified. 11 The same procedure was used to adjust estimates of heroin involvement. and outpatient ED visits, we determined that our microdata contains one-half to two-thirds of all ED visits for opioid overdoses, depending on the state and year. 13 The ED visit microdata include information on patient characteristics, diagnoses, procedures, and charges. Since the SEDD are not available for every year, and some state files are prohibitively expensive, our micro data cover the following states and years: Arizona (2005 Arizona ( -2014 , Kentucky (2008 ), Florida (2005 -2014 , Maryland (2002 ), and New Jersey (2004 , 2006 -2103 . To increase the geographical representation of our data, we also obtained state-level aggregated ED visit records from the 11 Over the full time period (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) , the overall drug mortality rate was 10.75 per 100,000. The opioid-involved death rate without imputations was 4.04 per 100,000. The adjustments increased this by around one-third, to 5.35 per 100,000. 12 Further information on the HCUP online aggregated data access system is available at: http://hcupnet.ahrq.gov. 13 Obtaining information on ED visits resulting in an inpatient stay would have required the purchase an additional product from HCUP for each state year.
HCUPnet system (which provides a click-through public-access system for accessing aggregated data) for 15 states in selected years. Specifically, we obtained state counts of ED visits (including those that did and did not subsequently result in an inpatient admission) for the following states and years: Arizona ( Carolina ( 2005 -2013 , Tennessee (2005 -2013 , Utah (2000 -2011 , 2013 ), and Vermont (2002 -2013 . The level of data available for each state and year combination is displayed in Table 1 .
Unlike the mortality data which codes reason for death by ICD-10 codes, the ED data are coded by ICD-9-CM codes. To ensure that our ED results are comparable to our mortality data, we used a CDC crosswalk that links ICD-10 cause of death and ICD-9-CM diagnosis codes for various categories of drug poisoning (CDC 2013 Table 2 contains summary statistics for our county-level data. Figure 1 illustrates the relationship between our main dependent variables, the death rate (per 100,000) from all drugs and from opioids, and the unemployment rate, our primary proxy for macroeconomic conditions. Over the entire period, 49.7% of drug deaths involved opioids, 17.1% involved heroin, and 38.7% of deaths involved only drugs other than heroin or opioids. 16 All three rates have risen over time. (39.50%) and the rate of all drug related ED visits increased by 13.70 per 100,000 (8.0%). These data come from the National Emergency Department Sample (NEDS), a 20% sample of records from all participating states (but not containing state identifiers) disseminated through HCUP.. The NEDS estimates are based upon the entire set of SID and SEDD data and are weighted to be nationally representative. We plot the national estimates based upon the NEDS here rather than state-level estimates based upon the SEDD data for the five states used in our analysis for expositional clarity.
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Figure 3 also highlights a key distinction between the mortality and emergency department data. Opioid deaths are responsible for roughly half of all drug deaths in any given year, while opioids ED visits compose only 13.88% of all drug ED visits. Eight categories of drugs constitute approximately 60% of the drug poisoning ED visits in any given year: opioids, benzodiazepines, heroin, anti-depressants, aromatic analgesics (acetaminophen), insulin, anti-psychotics, and cocaine. all other majority drug categories has remained constant or declined. 20 The NEDS further allows us to determine the percentage of in-hospital deaths that occur after an ED overdose visit for each drug type. 21 Cocaine, heroin, and opioids are by far the deadliest of the seven major drug categories resulting in around two to three times more deaths per visit than the other four top drug categories.
For every one-hundred ED visits for cocaine poisoning there are approximately 1.5 in-hospital deaths. Similarly, 1.41% of heroin and 1.15% of opioid overdose ED visits result in an in-hospital death. The death rate associated with an ED visit for a benzodiazepine overdose is roughly one-third or 0.42%. The weighted average death rate of an ED visit for the remaining four categories (antidepressants, anti-psychotics, insulin, and aromatic analgesics) is 0.36%.
III. Empirical Approach
In our main specification, the dependent variable, Y jt is the mortality or ED visit rate, per 100,000, in county j and year t, and U jt , the county annual unemployment rate, is the main proxy for macroeconomic conditions. We include county and year fixed-effects (C j and t ) in all of the county-20 Similar figures created for each state using the micro-data display consistent results. 21 This includes all deaths that occur in the ED as well as all deaths that occur in any related inpatient stay following an admission from the ED.
level models, to control for all potential confounding factors that vary across counties but are fixed over time, as well as determinants of mortality or ED visits that differ nationally across time.
Macroeconomic conditions may also have worsened (or improved) in areas that for other reasons were on different trajectories in terms of drug mortality. If so, a model with county and year fixed effects could still incorrectly attribute a continuing pre-existing trend in mortality to changes in unemployment rates. Our main strategy for addressing this is to include county-specific linear time trends in our preferred specifications.
Another concern is that changes in local policies influencing drug mortality or ED visits could have changed over time and been spuriously correlated unemployment. The most important of these policies -such as prescription drug monitoring programs, recreational or medical marijuana legalization, and Medicaid policies, among many others -will have occurred at the state rather than county level. In our county-level analysis, we are able to include state-by-year fixed effects (µ st ) to control for these potential confounders. Theoretically, we could simultaneously include both countyspecific time trends and state-by-year fixed-effects in our models. However, doing so for every county in the United States, leaves our model with no useful variation. 22 As an alternative, we include a county specific time trend for the largest 5% of counties in the United States, and then include additional time trends for the next nineteen vigintiles (5% bins) of the population. 23 This allows the largest counties to have their own unique linear trends and for similar-sized counties to have a common trend. 24 An additional rationale for this strategy is that the largest counties may have idiosyncratic issues related to opioid and other drug problems. The largest counties may also have 22 Specifically, a regression of county unemployment rates over this time on a set of county FE, year FE, state by year FE and county linear time trends has an adjusted R 2 of 0.96. 23 We use 1999 as the year to calculate population percentiles for the mortality data and 2008 as the year for the emergency department data. The mortality data can use any year as our sample is a strongly balanced panel so we pick the earliest year. The ED data uses 2008 as it is the first year that contains data for every state by race/ethnicity. 24 Our findings are not sensitive to the 5% cutoff and are robust to a variety of linear time trends as shown Table A2 in the Appendix. unique approaches to dealing with the drug epidemic. More generally, the resources available to combat the opioid crisis may vary systematically with population size.
Several points about our preferred regression specification deserve mention. First, given comprehensive controls for state and time-specific determinants, we generally do not include additional supplementary covariates. One exception is that some models contain controls for median incomes to examine whether these represent a likely mechanism for some of the effect of changing macroeconomic conditions. Second, we use levels, rather than natural logs, as the dependent variable. This is done because some counties (particularly smaller ones) will have zero values for the dependent variables in at least some years.
25 Third, we weight observations by population, to obtain nationally representative treatment effects. By contrast, unweighted estimates would overstate the influence of treatment effects in small counties. Fourth, the tables display robust standard errors with clustering at the county level, which is the level of variation of our key unemployment rate regressor.
There are pros and cons to using counties as the unit of observation, rather than some larger geographic aggregate, such as states. On the one hand, there is likely to be more error in the measurement of both mortality and unemployment rates at smaller geographic units. 26 On the other, county within the same state could face different economic climates and what happens far away may not affect lives as much as what happens nearby (e.g. in funding of public health). However, there is a further question regarding the level of geographic aggregation at which the macroeconomic effects actually occur. In this regard, Lindo's (2015) conclusion that more disaggregated analyses will often understate the extent to which downturns affect health is particularly instructive. For our application, an additional advantage of using the broader level of geography is that while county-level mortality 25 Prior related research (e.g. Ruhm, 2000) shows that comparable predicted effects are obtained using linear versus log-linear specifications. An alternative would be to estimate zero inflated negative binomial models, although the interpretation of the coefficients in such specifications would be somewhat less transparent. 26 The greater measurement error in county than state unemployment rates is well known (see for example Ganong and Liebman 2013) . Errors in classifying the county of residence at death have been less studied but Pierce and Denison (2006) We also conduct a large number of specification checks. For example, since the relationship between unemployment rates and macroeconomic conditions may have changed over time, we estimate supplemental models with shorter time windows of analysis. 27 We also allowed for heterogenous relationships between economic condition and drug adverse outcomes (across factors such as county population density, education levels and industrial structure) by estimating models that exclude categories of counties (or years). For instance, when looking for heterogeneity across education levels, we divide counties into quintiles based on the percent of high school graduates and then examine the sensitivity of the results to excluding one education quintile at a time. We also estimate models where the key macroeconomic variables are employment-to-population ratios, rather than unemployment rates. Table 3 shows five county-level specifications for our dependent variables of primary interest: the opioid-involved drug death rate, the all drug death rate, the opioid overdose ED visit rate, and the all drug overdose ED visit rate. The first column shows the specification with only county and year fixed effects. The second adds state-by-year fixed effects, while the third instead includes county time trends. County time trends include a county specific time trend for the largest 27 For instance, declines in labor force participation rates were particularly pronounced during the "great recession" that began in 2007, when compared to other economic downturns (Shierholz, 2012 ).
IV. County-Level Results
5% of counties in the United States, and a time trend for the next nineteen vigintiles (5% bins) of the population. The fourth column includes both county time trends and state-by-year fixed effects. The fourth column is our preferred specification as displayed in Equation 1. We view the models in columns (2) and (3) as superior to that in column (1) because they better control for possible confounding factors. However, we generally prefer models that include state-by-year fixed effects since, as mentioned, many potential policy determinants are likely to vary across both time and states, but less so across counties within states. Finally, column (5) is the same as column (4), except that it also controls for state median income. Although the income coefficient is positive and significant for the mortality outcomes (indicating a protective effect of incomes), its inclusion generally does not materially affect the estimated macroeconomic effect, consistent with results often obtained in previous related research (e.g. Ruhm, 2000) .
Turning to the main findings, the statistically significant unemployment coefficient of 0.12 for opioid-involved drug deaths, in column (4) implies that a one percentage point rise in the county unemployment rate is predicted to increase opioid fatalities by a statistically significant 0.12 per 100,000, representing a 2.2 percent growth from the sample average of 5.35 per 100,000. A one standard deviation change in the unemployment rate corresponds to 3.25 percentage points, suggesting effect sizes of around a 0.39 per 100,000, or a 7.3 percent, increase in fatal opioid overdoses. This also implies an unemployment rate elasticity of around 0.17. 28 Considerably larger coefficients are obtained in models that exclude state-by-year fixed-effects (columns 1 or 3) but, as mentioned, we view it as preferable to control for them.
The estimated unemployment rate effect for all drug fatalities is also highly significant but again is somewhat sensitive to the inclusion of state-year fixed-effects versus county-specific time trends. In the preferred model (column 4), a one-point rise in unemployment predicts a 0.18 per 100,000 increase in drug mortality rates, corresponding to a 1.7 percent increase from the sample average of 10.77 per 100,000, and an unemployment rate elasticity of around 0.13. Moreover, results from the preferred specification suggest that around two-thirds of the macroeconomic effect on drug mortality operates through opioid-related deaths. We confirmed this by estimating our preferred specification where the dependent variable was non-opioid related drug deaths (see Appendix Table   A4 ). The unemployment coefficient was (a statistically significant) -0.06, accounting for one-third of the total effect.
The two lower panels of Table 3 show results for drug-related ED visits, rather than deaths.
The samples are smaller-being restricted to selected county-year observations from five statesleading us to anticipate less precise estimates. Nevertheless, we find that, as with mortality rates, there is a strong and significant positive relationship between opioid-related overdose ED visits and unemployment rates that is relatively robust across specifications. In the model with state-year fixedeffects and county time trends (column 4), a one percentage point unemployment rate increase predicts a 0.82 per 100,000, or 6.0 percent increase in opioid ER visits, corresponding to an elasticity of around 0.50. The results for all drug ED visits are more sensitive to the choice of specifications, and statistically insignificant, but still suggestive of a countercyclical macroeconomic effect.
Specifically, in our preferred model, a one-point rise in unemployment predicts a statistically insignificant increase of 0.44 per 100,000, or 0.5 percent increase in all drug-related ED visits. This imprecise result for all ED visits related to drug poisonings is not implausible since there is a much larger set of drugs which could send one to the ED, but are less likely to result in death. Furthermore,
given that opioid overdose ED visits reflect a small share (13.88%) of all drug overdose ED visits, it is likely that our analysis is not powered enough to detect any plausible minimum effect size. Without performing a formal power analysis, this can be illustrated in a simple example. Consider the impact of a one percentage point increase in the unemployment rate, our model predicts that the opioid ED rate would increase by 6.0%, from 13.54 to 14.35 per 100,000. If this increase in opioid ED visits occurs and nothing else changes, then then mean total drug overdose ED rate would rise from 97.52 to 98.33, a 0.83% increase. Given that the standard deviation is 36.91 (37.85% of the mean), it seems unlikely that we will be able to credibly detect such a small increase. Indeed, the point estimate we find (0.44) is well within the expected order of magnitude, but is imprecisely estimated.
We next examine whether the effects differ across race/ethnicity groups. Table 4 provides results from our preferred specification with county time trends and state-by-year fixed-effects for each race/ethnic group. 29 The first column of Table 4 repeats the preferred specification (column (4)) from Table 3 , and presents the results from the full sample. The remaining columns present the results for whites, blacks, and Hispanics, respectively. As mentioned, Hispanic origin is not consistently classified in the ED visit data, so we do not present those results for Hispanics.
The countercyclical variation in opioid-involved deaths is primarily driven by effects on whites, where a one-point rise in unemployment predicts a highly significant 0.16 per 100,000 (or 2.5 percent) mortality increase. Conversely, the predicted effects are negative for blacks (-0.12 per 100,000) and positive but smaller for Hispanics (0.5 per 100,000). This finding is not unexpected as there are clear common trends between white opioid death rate and the total opioid death rate depicted in Figure 3 . 30 It is worth pointing out that the smaller estimates for nonwhites often represent lower levels for mortality risk, rather than smaller percentage effects. For instance, the statistically significant 0.05 unemployment coefficient for Hispanics in the model corresponds to a 3.1 percent growth from the relatively low average rate of 1.60 per 100,000, which is larger than the corresponding relative change for whites.
29 Tables A6 -A8 in the Appendix report results across a variety of specifications by race, mirroring Table 3 . 30 There are similar observable common trends between the total and white opioid ED visit rates in the ED data series.
The predicted macroeconomic effects on all drug deaths are also dominated by whites with a 0.27 per 100,000 (2.5 percent) increase anticipated to result from a one-point rise in the unemployment rate. Corresponding estimates are -0.19 per 100,000 for blacks and from .09 per 100,000 for Hispanics. For opioid-related ED visits the patterns are somewhat different, with strong countercyclical predicted effects for both whites -where a one-point increase in unemployment is expected to raise ED visits by 0. 76 per 100,000 or 4.4% percent -and blacks -a 1.03 per 100,000 or 15.3% percent in both models. However, the results for blacks and Hispanics should be interpreted with considerable caution as they are often reasonably sensitive to the choice of specifications. For instance, small and statistically insignificant unemployment coefficients are obtained for blacks, when examining all drug or opioid-related mortality rates, in models that include county and year fixed-effects and county-specific time trends but not state-by-year fixed-effects. Table 5 replicates the previous analysis but at the state rather than county-level. When looking at ED visits, we now utilize aggregated information from 15 states (rather than for the 5 states for which we have micro-data). Also, observations are weighted by the relevant state (rather than county) population and standard errors are clustered at the state-level. Our preferred specification includes state and year fixed-effects, as well as state-specific time trends. Appendix Table A1 contains relevant sample means for the outcomes and explanatory variables for the state level data.
V. State-Level Results
The first two columns of the table present full-sample estimates, with separate findings for whites, blacks and nonwhites shown in columns (3) through (6). The full sample results in columns
(1) and (2) are largely consistent with those observed using county-level data. Specifically, drug and opioid-related drug deaths, as well as opioid-related ED visits, are all strongly countercyclical. For example, a one-point increase in the unemployment rate is predicted to raise the full sample opioidrelated mortality rate by 0.33 per 100,000, a growth of 6.2 percent and indicating an elasticity of around 0.39. Similarly, a one-point increase in the unemployment rate increases the opioid ED visits rate by 3.12 (6.2%) with small positive (but statistically insignificant) predicted effects on drug ED visits. Although this pattern of results is quite similar to our county-level findings presented earlier, the magnitude is larger for each coefficient. This is consistent with Lindo's (2015) evidence that macroeconomic effects are often understated when using county-level data. 31 Once again, the estimates suggest that almost all of the predicted increase in drug deaths is due to opioid-related mortality, as evidenced by the similar (0.35 vs. 0.33) unemployment coefficients for the two dependent variables.
The third through eighth columns of Table 5 again indicate that the mortality effects are primarily due to changes among whites and, more generally, that the countercyclical variation in opioid-related deaths and ED visits is very strong for them. Interestingly, while the unemployment coefficients on drug and opioid mortality were negative (in at least some specifications) for blacks when using county-level data, they reverse sign (but are often insignificant) when using state-level data. This provides further evidence of the sensitivity of the estimates to samples or specifications for blacks, suggesting that we should be cautious about making conclusive statements about the macroeconomic effects for this group. Conversely, for Hispanics, the evidence of a countercyclical variation in drug deaths is obtained using both county and state level data.
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31 Another important driver of the difference in coefficient size for opioid ED visit rate between our preferred countylevel specification (.82) and our preferred state-level specification (3.12) is due to a difference in data. The countylevel ED data count the number of individuals with an opioid overdose diagnosis, while the state-level ED data count the number of opioid overdose ED visits (of which there could be more than one per individual). Interestingly, a one percentage point increase in the unemployment rate has similar percentage effects on county-level opioid ED visits (6%) and state-level ED visits by 6.2%. 32 We also estimated models for heroin-related ED visits. However, these showed no clear pattern, ranging from strongly and significantly positive to strongly and significantly negative, and where highly sensitive to the choice of specifications. These results are displayed in the Appendix in Table A5 . The majority of the coefficients are not statistically different from zero. Thus we cannot make statements about the relationship between heroin abuse and local macroeconomic conditions
VI. Robustness Checks
Our results to this point indicate that the drug mortality is strongly counter-cyclical with the most important role being played by overdose deaths involving opioids. Opioid overdoses that result in an emergency department visit are also counter-cyclical and both of these effects are strongly driven by the effects of macroeconomic conditions on whites. Conversely, the results for blacks and
Hispanics are more sensitive to the choice of model specification, suggesting difficulties in making conclusive statements for these demographic groups. We next conducted a variety of further tests of the robustness of these results to changes in samples or specifications.
Given our non-traditional county linear time trends, we first confirmed that our results were not a function of this choice by replicating our full sample analysis using a variety of alternative time trend specifications. The results from this exercise, presented in Appendix Table A2 , show that the findings are robust. As in Table 3 , each specification contains county, year, and state-by-year fixedeffects, with standard errors clustered at the county level. The number of time trends included increases as we move down the table and, when doing so, the coefficients of interest gradually attenuate towards zero. However, our mortality findings are robust to every alternative linear time trend specification, the last row which includes a separate trend for each county. As discussed, the inclusion of this large number of time trends removes all remaining useful variation. Similarly, our ED findings are robust to a majority of alternative time trends, but given the smaller number of counties in our sample, the results are also insignificant when using commuter zone specific time trends.
We next examined whether the relationship between macroeconomic shocks and opioid abuse differed by time period. This is investigated in Figure A1 which shows, for our preferred county-level specification, the effect on the coefficients of systematically remove sets of three years at a time. Three year bins are chosen to ensure the full great recession period is removed in one specification, to insure that our results are not driven the recession or other short run macroeconomic events. The left side column has all deaths and the right side column shows corresponding effects for the ED visits.
For drug deaths, the coefficients and 95% confidence intervals are always well above 0, although they do fluctuate a bit. The estimate that excludes the Great Recession is marked by "08-10" is typical of the estimates obtained when removing other sub-periods. For opioid deaths we obtain a similar story of fairly consistent and strong effects, although some results are not quite statistically significant at the 10% level. Opioid-related ED visits show a similar, consistent and significant estimates when removing subperiods but we do not find significant results for any drug ED visit specifications. Table A1 in the Appendix summarizes the data used in the remaining robustness checks. We next tested whether the results were robust to using employment-to-population (EP) ratios rather than unemployment rates as the proxy for macroeconomics conditions. These results, summarized in Appendix Table A3 , are conducted at the state level since there is no readily available series of county EP ratios. These results are a virtual mirror (although slightly smaller in absolute value) of the findings in Table 4 , showing that the estimates are not sensitive to this choice.
We then explore whether the effects differ across urban and rural areas by successively excluding quintile of counties based upon 2010 population density. For these results, shown in Figure   A2 , the right column again refers to ED visits and the left column to deaths. The mortality findings are not driven by population density, with the slight exception that the coefficient on opioid deaths falls slightly and are significant at the 10% but not the 5% level when excluding the densest areas.
The results for ED visits for all drugs are again noisier and centered around zero, while those for opioid-related ED visits are statistically significant and consistent in magnitude across all quintiles.
Next, we performed the same exercise except systematically dropping counties by quintile of 2010 high school graduation status ( Figure A3 ) and percent non-white ( Figure A4 ). Our main results are robust to these exclusions. were only available as a cross-section and so could not be used as an independent variable in our main analysis. Instead, we followed with the just described strategy of examining whether the areas most (or least) impacted by changes in manufacturing employment or foreign imports were driving our main findings. Once again, we obtained consistent coefficients across the omitted quintiles for each variable, indicating that those areas who lost the most manufacturing jobs and those areas who saw the greatest increase in imports did not drive our findings. Figure A7 performs a series of placebo tests, examining the unemployment coefficients on ED visit rates for causes not anticipated to be related to macroeconomic conditions. These included:
vomiting during pregnancy, open head wounds, broken legs or arms and broken noses. With the exception of broken noses, none of these were related to unemployment rates. Finally, Figure A8 decomposes the effect of the unemployment rate by age and payer type group for ED opioid overdose admission rates. The results show that opioid-related ED visits are driven by increases across all age groups and payer types, except for the elderly. While the point estimates for the elderly (and for
Medicare as an expected payer type) are positive, they are not statistically different from zero. This null finding for the elderly intuitively makes sense since job losses and economic declines during recessions should affect the working age population and children more than the elderly.
V. Discussion
A long literature examines the relationship between health and economic declines, in the midst of a growing awareness and analysis of the alarming growth in opioid deaths and related adverse events. However, so far there has been little research rigorously examining possible connections between the two. This paper uses county and state data on mortality rates, as well as on ED visits from a subset of states to examine these issues.
We obtain strong evidence that opioid-related deaths and emergency room visits increase during times of economic weakness, although the results vary somewhat with the unit of observation (county vs. state) and the specifications estimated. In the main county-level models, our preferred specification indicates that a one percentage point increase in the unemployment rate raises the predicted opioid-involved mortality rates by 0.12 per 100,000, corresponding to 2.2 percent growth and an unemployment elasticity of mortality of around 0.17. These effects are largely driven by changes in the opioid mortality rates of whites, with much smaller (but still mostly positive) increases predicted for Hispanics. Opioid-related emergency department visits are also predicted to rise when in bad economic times, in most specifications, with strong effects here observed for blacks as well as whites. There are weaker, and less consistent, results for other mortality and emergency department outcomes (e.g. heroin-involved or other drug deaths), although often with results in that are in the same direction as for opioids.
When conducting the analysis at the state (rather than county, level) negative economic shocks are estimated to have bigger adverse effects on drug related mortality and ED visits. For instance, a one-point rise in unemployment is predicted to increase overall opioid-related mortality by 0.33 per 100,000, almost three times the size of the county-level estimates, corresponding to growth of 6.2 percent and an unemployment elasticity of around 0.39. These larger estimates could occur because counties are too narrow a unit of observation to observe the full effects, as Lindo (2015) or because the county-level models are more fully able to control for potential confounding factors.
Our results should be interpreted in light of several limitations. First, while we have data for all deaths to US residents, the information on emergency department visits is far more restricted, especially in our county level analysis where we only have data for five states. Second, although we use the two measures of macroeconomic conditions most often used in the related literature (unemployment rates and employment to population rates), a variety of others could be considered including some like home foreclosures at the zip-code level (Currie and Tekin, 2015) , or stock market losses at the national level (Schwartz, et al., 2012) that measure different dimensions of economic decline. Third, there could be errors in the recording of the specific drugs involved in fatal overdoses and in the reasons for ED visits. We use imputation procedures to minimize effects of the former, but cannot be sure that the methods are completely successful. Finally, it is unclear what is the "best" model specification or unit of analysis. We have attempted to surmount this issue by providing results for a wide variety of models and while most results are robust to these alternatives, some are not (e.g. the effects for blacks).
There are numerous causal pathways that link macroeconomic developments to health behaviors and their consequences but we know little about the mechanisms for the effects observed here. During periods of economic weakness, lower incomes might be expected to reduce purchases and use of legal or illicit drugs (Riddell and Riddell, 2006; Dobkin and Puller, 2007) . Similarly, mechanisms emphasizing reductions in time costs (e.g. having more time to engage in time-intensive health-improving behaviors like exercise or recovery treatment programs) would lead to better outcomes in bad economic times. Neither of these appear to be a dominant factor for opioids or other drugs that lead to emergency department visits or deaths, since both are predicted to increase as a result of negative macroeconomic shocks. 33 On the other hand, our results could be consistent with a role for supply-side factors, such as the loss of health insurance or of public health funding for treatment or prevention programs during periods of economic weakness.
We suspect that the dominant factor linking macroeconomic conditions to health outcomes studies in this paper may be that fatal and near fatal abuse of opioids often (and increasingly over time) reflects a physical manifestation of mental health problems that have long been known to increase in periods of economic weakness. 34 In this regard, we note that although opioids are prescribed to treat pain, there are strong linkages between pain, mental health problems and the use of analgesics. 35 With the increased availability of prescription opioids (and reductions in heroin prices), it seems likely that adverse economic times lead to increased prevalence of substance use that some of this increased use leads to emergency department visits or death. Obtaining a better understanding of the causal pathways for the results we observe is an important direction for future research. 33 Worsening economic conditions could lead to reductions in some types of drug use but with changes in the composition of consumption such that adverse events increase. 34 This dates back to Durkheim's (1897) work on suicides and includes a great deal of later work including that by Hamermesh and Soss (1974) , and in the more closely related literature to Ruhm (2000) and others. 35 Depression and other forms of mental illnesses increase the experience of pain; pain is associated with more depressive symptoms and the two share many of the same biological pathways (Bair et al. 2003) Persons with depression, dysthymia and generalized anxiety or panic disorders use narcotics at relatively high rates (Sullivan et al. 2006; Braden et al. 2009) 
